ivermectin + malathion
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Lice Infestations
Conditions
Lice Infestations
Trial Timeline
Feb 1, 2004 → Oct 1, 2004
NCT ID
NCT00819520About ivermectin + malathion
ivermectin + malathion is a phase 3 stage product being developed by Johnson & Johnson for Lice Infestations. The current trial status is completed. This product is registered under clinical trial identifier NCT00819520. Target conditions include Lice Infestations.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00819520 | Phase 3 | Completed |
Competing Products
11 competing products in Lice Infestations
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| MALG + Ovide (malathion) lotion 0.05% + Permethrin 1% | Sun Pharmaceutical | Phase 3 | 77 |
| Ivermectin Lotion, 0.5% + SKLICE (ivermectin) Lotion, 0.5% + Vehicle of the Test product | Sun Pharmaceutical | Phase 1 | 33 |
| MALG | Sun Pharmaceutical | Phase 2 | 52 |
| Abametapir Lotion 0.74% w/w + Vehicle Lotion | Dr. Reddy's Laboratories | Phase 3 | 74 |
| Ha44 Gel 0.74% w/w | Dr. Reddy's Laboratories | Phase 2 | 49 |
| Abametapir Lotion 0.74% w/w + Vehicle Lotion | Dr. Reddy's Laboratories | Phase 3 | 74 |
| Abametapir Lotion 0.74% w/w | Dr. Reddy's Laboratories | Phase 1 | 30 |
| Abametapir Lotion 0.74% w/w + Sodium Lauryl Sulfate + Saline 0.9% + Placebo | Dr. Reddy's Laboratories | Phase 1 | 30 |
| Abametapir Lotion 0.74% w/w + Vehicle Lotion | Dr. Reddy's Laboratories | Phase 2 | 49 |
| Ha44 Gel | Dr. Reddy's Laboratories | Phase 2 | 49 |
| Ivermectin 0.5% Topical Application Lotion + Ivermectin 0.5% Topical Application Lotion [SKLICE] + Placebo 0% Lotion | Mayne Pharma Group | Phase 3 | 69 |